University of Groningen Revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis Bossuyt,

[1]  P. Merkel,et al.  Nomenclature of Cutaneous Vasculitis , 2018, Arthritis & rheumatology.

[2]  P. Vermeersch,et al.  Individual values of antineutrophil cytoplasmic antibodies do not correspond between antigen-specific assays , 2017, Clinical chemistry and laboratory medicine.

[3]  P. van Paassen,et al.  A multicentre study to improve clinical interpretation of proteinase-3 and myeloperoxidase anti-neutrophil cytoplasmic antibodies , 2017, Rheumatology.

[4]  I. Zegers,et al.  Development of a Certified Reference Material for myeloperoxidase-anti-neutrophil cytoplasmic autoantibodies (MPO-ANCA). , 2017, Clinica chimica acta; international journal of clinical chemistry.

[5]  X. Bossuyt,et al.  Antineutrophil cytoplasmic antibodies: reporting and diagnostic strategies , 2017, Annals of the rheumatic diseases.

[6]  X. Bossuyt,et al.  Antineutrophil cytoplasmic antibodies: appropriate use and interpretation , 2017, Annals of the rheumatic diseases.

[7]  S. Moiseev,et al.  Testing for antineutrophil cytoplasmic antibodies (ANCAs) in patients with systemic vasculitides and other diseases , 2016, Annals of the rheumatic diseases.

[8]  P. van Paassen,et al.  Detection of antineutrophil cytoplasmic antibodies (ANCAs): a multicentre European Vasculitis Study Group (EUVAS) evaluation of the value of indirect immunofluorescence (IIF) versus antigen-specific immunoassays , 2016, Annals of the rheumatic diseases.

[9]  A. Heng,et al.  Antineutrophilic cytoplasmic antibody-associated vasculitis and malignant hemopathies, a retrospective study of 16 cases. , 2017, Joint, bone, spine : revue du rhumatisme.

[10]  M. Segelmark,et al.  The clinical presentation and therapy of diseases related to anti-neutrophil cytoplasmic antibodies (ANCA). , 2016, Autoimmunity reviews.

[11]  Joanna Collison.  Vasculitis syndromes: New ANCA assays put through their paces , 2016, Nature Reviews Rheumatology.

[12]  D. Cornec,et al.  ANCA-associated vasculitis — clinical utility of using ANCA specificity to classify patients , 2016, Nature Reviews Rheumatology.

[13]  P. van Paassen,et al.  Evaluation of automated multi-parametric indirect immunofluorescence assays to detect anti-neutrophil cytoplasmic antibodies (ANCA) in granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA). , 2016, Autoimmunity reviews.

[14]  P. van Paassen,et al.  The avidity of PR3‐ANCA in patients with granulomatosis with polyangiitis during follow‐up , 2016, Clinical and experimental immunology.

[15]  P. Merkel,et al.  Vasculitis in patients with inflammatory bowel diseases: A study of 32 patients and systematic review of the literature. , 2016, Seminars in Arthritis & Rheumatism.

[16]  J. Ménard,et al.  Antineutrophil Cytoplasmic Antibodies Associated With Infective Endocarditis , 2016, Medicine.

[17]  R. Altwegg,et al.  Inflammatory bowel diseases in anti-neutrophil cytoplasmic antibody-associated vasculitides: 11 retrospective cases from the French Vasculitis Study Group. , 2015, Rheumatology.

[18]  R. Grau.  Drug-Induced Vasculitis: New Insights and a Changing Lineup of Suspects , 2015, Current Rheumatology Reports.

[19]  P. van Paassen,et al.  Proteinase 3-ANCA Vasculitis versus Myeloperoxidase-ANCA Vasculitis. , 2015, Journal of the American Society of Nephrology : JASN.

[20]  A. Wiik,et al.  A historical essay on detection of anti-neutrophil cytoplasmic antibodies. , 2015, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[21]  G. Kaplan,et al.  PR3-ANCA: A Promising Biomarker in Primary Sclerosing Cholangitis (PSC) , 2014, PloS one.

[22]  D. Bogdanos,et al.  Simultaneous Automated Screening and Confirmatory Testing for Vasculitis-Specific ANCA , 2014, PloS one.

[23]  F. Moosig,et al.  Current and emerging techniques for ANCA detection in vasculitis , 2014, Nature Reviews Rheumatology.

[24]  B. Iung,et al.  Prevalence of Antineutrophil Cytoplasmic Antibodies in Infective Endocarditis , 2014 .

[25]  S. Marchi,et al.  Anti-PR3 and anti-MPO antibodies are not present in sera of patients with pulmonary tuberculosis , 2014, Rheumatology International.

[26]  L. Mouthon,et al.  Diagnosis and classification of eosinophilic granulomatosis with polyangiitis (formerly named Churg-Strauss syndrome). , 2014, Journal of autoimmunity.

[27]  Mårten Segelmark,et al.  Diagnosis and classification of Goodpasture's disease (anti-GBM). , 2014, Journal of autoimmunity.

[28]  J. Niles,et al.  Trojan horses: drug culprits associated with antineutrophil cytoplasmic autoantibody (ANCA) vasculitis , 2014, Current opinion in rheumatology.

[29]  A. Forbes,et al.  PR3-ANCA: a promising biomarker for ulcerative colitis with extensive disease. , 2013, Clinica chimica acta; international journal of clinical chemistry.

[30]  L. Dahmoush,et al.  ANA (+) ANCA (+) systemic vasculitis associated with the use of minocycline: case-based review , 2013, Clinical Rheumatology.

[31]  Min Chen,et al.  Epitope Analysis of Anti-Myeloperoxidase Antibodies in Patients with ANCA-Associated Vasculitis , 2013, PloS one.

[32]  P. Heeringa,et al.  Epitope specificity determines pathogenicity and detectability in ANCA-associated vasculitis. , 2013, The Journal of clinical investigation.

[33]  J. Crespo,et al.  Presence of Anti-proteinase 3 Antineutrophil Cytoplasmic Antibodies (Anti-PR3 ANCA) as Serologic Markers in Inflammatory Bowel Disease , 2013, Clinical Reviews in Allergy & Immunology.

[34]  P. Merkel,et al.  2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. , 2013, Arthritis and rheumatism.

[35]  M. Cusini,et al.  Case-based review , 2013 .

[36]  M. Cusini,et al.  Automated interpretation of ANCA patterns - a new approach in the serology of ANCA-associated vasculitis , 2012, Arthritis Research & Therapy.

[37]  S. Vermeire,et al.  Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosis. , 2012, Journal of Crohn's & colitis.

[38]  J. C. Cohen Tervaert,et al.  Automatic Reading of ANCA-Slides: Evaluation of the AKLIDES System , 2012, Clinical & developmental immunology.

[39]  Panos Deloukas,et al.  Genetically distinct subsets within ANCA-associated vasculitis. , 2012, The New England journal of medicine.

[40]  J. C. Cohen Tervaert,et al.  Antineutrophil Cytoplasmic Autoantibodies: How Are They Detected and What Is Their Use for Diagnosis, Classification and Follow-up? , 2012, Clinical Reviews in Allergy & Immunology.

[41]  L. Bianchi,et al.  Development and performance evaluation of novel chemiluminescence assays for detection of anti-PR3 and anti-MPO antibodies. , 2012, Clinica chimica acta; international journal of clinical chemistry.

[42]  Z. Amoura,et al.  Routine use of Zenit RA, a novel chemiluminescent immunoanalyzer in autoimmune disease diagnosis , 2012, Autoimmunity Highlights.

[43]  M. Trillini,et al.  Infective endocarditis mimics ANCA associated glomerulonephritis. , 2012, Caspian journal of internal medicine.

[44]  C. Alpers,et al.  Anti-Proteinase 3 Anti-Neutrophil Cytoplasm Autoantibodies Recapitulate Systemic Vasculitis in Mice with a Humanized Immune System , 2012, PloS one.

[45]  P. Heeringa,et al.  Pathogenesis of ANCA-associated vasculitis: recent insights from animal models , 2012, Current opinion in rheumatology.

[46]  H. Rennke,et al.  Contaminated cocaine and antineutrophil cytoplasmic antibody-associated disease. , 2011, Clinical journal of the American Society of Nephrology : CJASN.

[47]  V. Viallon,et al.  Sialylation levels of anti-proteinase 3 antibodies are associated with the activity of granulomatosis with polyangiitis (Wegener's). , 2011, Arthritis and rheumatism.

[48]  U. Specks,et al.  Discrimination and variable impact of ANCA binding to different surface epitopes on proteinase 3, the Wegener's autoantigen. , 2010, Journal of autoimmunity.

[49]  A. Timms,et al.  Does a gating policy for ANCA overlook patients with ANCA associated vasculitis? An audit of 263 patients , 2010, Journal of Clinical Pathology.

[50]  Shigeto Kobayashi,et al.  EULAR points to consider in the development of classification and diagnostic criteria in systemic vasculitis , 2010, Annals of the rheumatic diseases.

[51]  P. Vermeersch,et al.  Comparative analysis of different approaches to report diagnostic accuracy. , 2010, Archives of internal medicine.

[52]  M. Segelmark,et al.  Epitope shift of proteinase‐3 anti‐neutrophil cytoplasmic antibodies in patients with small vessel vasculitis , 2010, Clinical and experimental immunology.

[53]  P. Vermeersch,et al.  Use of likelihood ratios can improve the clinical usefulness of enzyme immunoassays for the diagnosis of small-vessel vasculitis. , 2009, Clinical chemistry.

[54]  T. Buettner,et al.  High‐sensitivity Detection of Autoantibodies Against Proteinase‐3 by a Novel Third‐generation Enzyme‐linked Immunosorbent Assay , 2009, Annals of the New York Academy of Sciences.

[55]  P. van Paassen,et al.  EUROPLUS ANCA BIOCHIP mosaic: PR3 and MPO antigen microdots improve the laboratory diagnostics of ANCA-associated vasculitis. , 2009, Journal of immunological methods.

[56]  J. C. Cohen Tervaert,et al.  Fifty years of antineutrophil cytoplasmic antibodies (ANCA) testing: do we need to revise the international consensus statement on testing and reporting on ANCA? , 2009, APMIS. Supplementum.

[57]  X. Bossuyt.  Clinical performance characteristics of a laboratory test. A practical approach in the autoimmune laboratory. , 2009, Autoimmunity reviews.

[58]  Y. Shoenfeld,et al.  Infection and vasculitis , 2008, Rheumatology.

[59]  P. van Paassen,et al.  A novel enzyme-linked immunosorbent assay using a mixture of human native and recombinant proteinase-3 significantly improves the diagnostic potential for antineutrophil cytoplasmic antibody-associated vasculitis , 2008, Annals of the rheumatic diseases.

[60]  Ravi Kaul,et al.  Performance of the BioPlex 2200 Autoimmune Vasculitis kit. , 2009, Autoimmunity reviews.

[61]  H. Vanmaele,et al.  Determination of anti-neutrophil cytoplasmic antibodies in small vessel vasculitis: Comparative analysis of different strategies. , 2008, Clinica chimica acta; international journal of clinical chemistry.

[62]  J. Savige,et al.  Evaluation of a multiplex flow cytometric immunoassay to detect PR3- and MPO-ANCA in active and treated vasculitis, and in inflammatory bowel disease (IBD). , 2008, Journal of immunological methods.

[63]  K. Ghosh,et al.  Background noise of infection for using ANCA as a diagnostic tool for vasculitis in tropical and developing countries , 2008, Parasitology Research.

[64]  Kazuo Suzuki,et al.  Analysis of Risk Epitopes of Anti‐Neutrophil Antibody MPO‐ANCA in Vasculitis in Japanese Population , 2007, Microbiology and immunology.

[65]  P. van Paassen,et al.  Evaluation of the FIDIS Vasculitis Multiplex Immunoassay for Diagnosis and Follow‐up of ANCA‐Associated Vasculitis and Goodpasture's Disease , 2007, Annals of the New York Academy of Sciences.

[66]  D. Scott,et al.  Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies , 2006, Annals of the rheumatic diseases.

[67]  W. Gross,et al.  A novel high sensitivity ELISA for detection of antineutrophil cytoplasm antibodies against proteinase-3. , 2007, Clinical and experimental rheumatology.

[68]  George Notas,et al.  Comparison of a multiplex, bead-based fluorescent assay and immunofluorescence methods for the detection of ANA and ANCA autoantibodies in human serum. , 2006, Journal of immunological methods.

[69]  X. Bossuyt.  Serologic markers in inflammatory bowel disease. , 2006, Clinical chemistry.

[70]  Augustine S. Lee,et al.  A novel capture-ELISA for detection of anti-neutrophil cytoplasmic antibodies (ANCA) based on c-myc peptide recognition in carboxy-terminally tagged recombinant neutrophil serine proteases. , 2005, Journal of immunological methods.

[71]  Ming-hui Zhao,et al.  Anti-myeloperoxidase IgG subclass distribution and avidity in sera from patients with propylthiouracil-induced antineutrophil cytoplasmic antibodies associated vasculitis. , 2005, Clinical immunology.

[72]  R. Sinico,et al.  Value of a New Automated Fluorescence Immunoassay (EliA) for PR3 and MPO‐ANCA in Monitoring Disease Activity in ANCA‐Associated Systemic Vasculitis , 2005, Annals of the New York Academy of Sciences.

[73]  J. Damoiseaux,et al.  Evaluation of a New Fluorescent-Enzyme Immuno-Assay for Diagnosis and Follow-up of ANCA-Associated Vasculitis , 2005, Journal of Clinical Immunology.

[74]  T. Links,et al.  Occurrence of antineutrophil cytoplasmic antibodies and associated vasculitis in patients with hyperthyroidism treated with antithyroid drugs: A long-term followup study. , 2005, Arthritis and rheumatism.

[75]  D. Sinclair,et al.  The effect of a symptom related “gating policy” on ANCA requests in routine clinical practice , 2004, Journal of Clinical Pathology.

[76]  P. Heeringa,et al.  Pathophysiology of ANCA-associated vasculitides: are ANCA really pathogenic? , 2003, The Netherlands journal of medicine.

[77]  A. Wiik,et al.  Addendum to the International Consensus Statement on testing and reporting of antineutrophil cytoplasmic antibodies. Quality control guidelines, comments, and recommendations for testing in other autoimmune diseases. , 2003, American journal of clinical pathology.

[78]  P. Heeringa,et al.  ANCA and anti-GBM antibodies in diagnosis and follow-up of vasculitic disease. , 2003, European journal of internal medicine.

[79]  J. Alcocer-Varela,et al.  Prevalence of antineutrophil cytoplasmic autoantibodies in patients with tuberculosis. , 2003, Rheumatology.

[80]  P. Heeringa,et al.  Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. , 2002, The Journal of clinical investigation.

[81]  J. Reveille,et al.  Guidelines for immunologic laboratory testing in the rheumatic diseases: an introduction. , 2002, Arthritis and rheumatism.

[82]  J. Katz,et al.  Using antineutrophil cytoplasmic antibody testing to diagnose vasculitis: can test-ordering guidelines improve diagnostic accuracy? , 2002, Archives of internal medicine.

[83]  D. Schroeder,et al.  Detection of anti-neutrophil cytoplasmic antibodies under actual clinical testing conditions. , 2002, Clinical immunology.

[84]  G A Colditz,et al.  Diagnostic performance of antineutrophil cytoplasmic antibody tests for idiopathic vasculitides: metaanalysis with a focus on antimyeloperoxidase antibodies. , 2001, The Journal of rheumatology.

[85]  P. Lamprecht,et al.  Prevalence and spectrum of rheumatic diseases associated with proteinase 3-antineutrophil cytoplasmic antibodies (ANCA) and myeloperoxidase-ANCA. , 2001, Rheumatology.

[86]  C. Kallenberg,et al.  Antineutrophil cytoplasmic antibodies to proteinase 3 in Wegener's granulomatosis: epitope analysis using synthetic peptides. , 2001, Kidney international.

[87]  H. L. V. van Duijnhoven,et al.  Evaluation of a simple dot-blot method for the detection of anti-neutrophil cytoplasmic antibodies directed against proteinase 3 and myeloperoxidase. , 2000, Clinical chemistry.

[88]  R. Gans,et al.  Antiproteinase 3- and antimyeloperoxidase-associated vasculitis. , 2000, Kidney international.

[89]  R. van Wijk,et al.  Clinical significance of anti-neutrophil cytoplasmic antibodies (ANCA) in autoimmune liver diseases. , 2000, Journal of hepatology.

[90]  C. Lovell,et al.  Antineutrophil cytoplasmic antibodies and HLA class II alleles in minocycline‐induced lupus‐like syndrome , 2000, The British journal of dermatology.

[91]  R J Falk,et al.  International Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies (ANCA) , 1999, American journal of clinical pathology.

[92]  M. Yaron,et al.  Clinical and immunological study of 7 patients with minocycline-induced autoimmune phenomena. , 1998, The American journal of medicine.

[93]  A. Wiik,et al.  Clinical evaluation of a capture ELISA for detection of proteinase-3 antineutrophil cytoplasmic antibody. , 1998, Kidney international.

[94]  P Lesavre,et al.  Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization. , 1998, Kidney international.

[95]  C. Langford,et al.  The diagnostic utility of c-ANCA in Wegener's granulomatosis. , 1998, Cleveland Clinic journal of medicine.

[96]  R. Falk,et al.  Diagnostic predictive value of ANCA serology. , 1998, Kidney international.

[97]  P. Merry,et al.  Antineutrophil cytoplasmic antibody-positive polyarthritis associated with minocycline therapy. , 1996, British journal of rheumatology.

[98]  C. Kallenberg,et al.  Development and standardization of solid phase assays for the detection of anti-neutrophil cytoplasmic antibodies (ANCA). A report on the second phase of an international cooperative study on the standardization of ANCA assays. , 1996, Journal of immunological methods.

[99]  R J Falk,et al.  Nomenclature of systemic vasculitides. Proposal of an international consensus conference. , 1994, Arthritis and rheumatism.

[100]  A. Wiik,et al.  The value of indirect immunofluorescence and solid phase techniques for ANCA detection. A report on the first phase of an international cooperative study on the standardization of ANCA assays. EEC/BCR Group for ANCA Assay Standardization. , 1993, Journal of immunological methods.

[101]  E. Schrumpf,et al.  Antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis, ulcerative colitis, and autoimmune diseases. , 1992, Gastroenterology.

[102]  P. Limburg,et al.  Predominance of IgGl and IgG4 subclasses of anti‐neutrophil cytoplasmic autoantibodies (ANCA) in patients with Wegener's granulomatosis and clinically related disorders , 1991, Clinical and experimental immunology.

[103]  D A Bloch,et al.  The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. , 2010, Arthritis and rheumatism.

[104]  D A Bloch,et al.  The American College of Rheumatology 1990 criteria for the classification of vasculitis. Summary. , 2010, Arthritis and rheumatism.

[105]  J. Tschopp,et al.  Wegener's autoantigen decoded , 1990, Nature.

[106]  P. Bygren,et al.  An ELISA for the detection of anti-neutrophil cytoplasm antibodies (ANCA). , 1990, Journal of immunological methods.

[107]  R. Goldschmeding,et al.  Autoantibodies against myeloid lysosomal enzymes in crescentic glomerulonephritis. , 1990, Kidney international.

[108]  M. Arnaout,et al.  Wegener9s granulomatosis autoantigen is a novel neutrophil serine proteinase [see comments] , 1989 .

[109]  C. Hack,et al.  Wegener's granulomatosis autoantibodies identify a novel diisopropylfluorophosphate-binding protein in the lysosomes of normal human neutrophils. , 1989, The Journal of clinical investigation.

[110]  M. Arnaout,et al.  Wegener's granulomatosis autoantigen is a novel neutrophil serine proteinase. , 1989, Blood.

[111]  A. Wiik.  Delineation of a standard procedure for indirect immunofluorescence detection of ANCA. , 1989, APMIS. Supplementum.

[112]  R. Falk,et al.  Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. , 1988, The New England journal of medicine.

[113]  T. H. The,et al.  AUTOANTIBODIES AGAINST NEUTROPHILS AND MONOCYTES: TOOL FOR DIAGNOSIS AND MARKER OF DISEASE ACTIVITY IN WEGENER'S GRANULOMATOSIS , 1985, The Lancet.

[114]  J. E. Moran,et al.  Segmental necrotising glomerulonephritis with antineutrophil antibody: possible arbovirus aetiology? , 1982, British medical journal.

[115]  Scott D. Thomson,et al.  An Introduction , 1977 .

[116]  E. Edwards,et al.  Fluorescent antiglobulin studies in leukopenic and related disorders. , 1959, The Journal of clinical investigation.

[117]  U. Stenman,et al.  Use of Likelihood Ratios Can Improve the Clinical Usefulness of Enzyme Immunoassays for the Diagnosis of Small-Vessel Vasculitis , 2022 .